메뉴 건너뛰기




Volumn 9, Issue 2, 2012, Pages 92-100

TNF revisited: Osteoprotegerin and TNF-related molecules in heart failure

Author keywords

Apoptosis; Biomarker; Cardiac hypertrophy; Extracellular matrix remodeling; Heart failure; Inflammation; OPG; Osteoprotegerin; Pathophysiology; TNF. Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; BIOLOGICAL MARKER; LIGAND; TUMOR NECROSIS FACTOR ALPHA;

EID: 84864881461     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-012-0088-6     Document Type: Article
Times cited : (29)

References (86)
  • 6
    • 0037195727 scopus 로고    scopus 로고
    • Inflammatory mediators and the failing heart: Past, present, and the foreseeable future
    • DOI 10.1161/01.RES.0000043825.01705.1B
    • Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91:988-98. (Pubitemid 35416635)
    • (2002) Circulation Research , vol.91 , Issue.11 , pp. 988-998
    • Mann, D.L.1
  • 8
    • 85047692516 scopus 로고    scopus 로고
    • Signalling pathways of the TNF superfamily: A double-edged sword
    • DOI 10.1038/nril184
    • Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745-56. (Pubitemid 41070815)
    • (2003) Nature Reviews Immunology , vol.3 , Issue.9 , pp. 745-756
    • Aggarwal, B.B.1
  • 9
    • 0038320263 scopus 로고    scopus 로고
    • The signaling adaptors and pathways activated by TNF superfamily
    • DOI 10.1016/S1359-6101(03)00021-2
    • Dempsey PW, Doyle SE, He JQ, Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 2003;14:193-209. (Pubitemid 36693141)
    • (2003) Cytokine and Growth Factor Reviews , vol.14 , Issue.3-4 , pp. 193-209
    • Dempsey, P.W.1    Doyle, S.E.2    He, J.Q.3    Cheng, G.4
  • 12
    • 0029670957 scopus 로고    scopus 로고
    • Tumor necrosis factoralpha and tumor necrosis factor receptors in the failing human heart
    • Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factoralpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-11.
    • (1996) Circulation , vol.93 , pp. 704-711
    • Torre-Amione, G.1    Kapadia, S.2    Lee, J.3
  • 15
    • 0037084504 scopus 로고    scopus 로고
    • All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction
    • Chung JY, Park YC, Ye H, Wu H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAFmediated signal transduction. J Cell Sci. 2002;115:679-88. (Pubitemid 34196328)
    • (2002) Journal of Cell Science , vol.115 , Issue.4 , pp. 679-688
    • Chung, J.Y.1    Park, Y.C.2    Ye, H.3    Wu, H.4
  • 16
    • 0642283970 scopus 로고    scopus 로고
    • Regulation of proliferation, survival and apoptosis by members of the TNF superfamily
    • DOI 10.1016/S0006-2952(03)00490-8, PII S0006295203004908
    • Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003;66:1403-8. (Pubitemid 38373326)
    • (2003) Biochemical Pharmacology , vol.66 , Issue.8 , pp. 1403-1408
    • Gaur, U.1    Aggarwal, B.B.2
  • 17
    • 2342464085 scopus 로고    scopus 로고
    • The two NF-κB activation pathways and their role in innate and adaptive immunity
    • DOI 10.1016/j.it.2004.03.008, PII S1471490604001000
    • Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25:280-8. (Pubitemid 38610351)
    • (2004) Trends in Immunology , vol.25 , Issue.6 , pp. 280-288
    • Bonizzi, G.1    Karin, M.2
  • 18
    • 77149136451 scopus 로고    scopus 로고
    • Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
    • Lutgens E, Lievens D, Beckers L, et al. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med. 2010;207:391-404.
    • (2010) J Exp Med , vol.207 , pp. 391-404
    • Lutgens, E.1    Lievens, D.2    Beckers, L.3
  • 21
    • 0036216193 scopus 로고    scopus 로고
    • Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure
    • Yndestad A, Damas JK, Geir EH, et al. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res. 2002;54:175-82.
    • (2002) Cardiovasc Res , vol.54 , pp. 175-182
    • Yndestad, A.1    Damas, J.K.2    Geir, E.H.3
  • 24
    • 0034702911 scopus 로고    scopus 로고
    • Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia
    • Jeremias I, Kupatt C, Martin-Villalba A, et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation. 2000;102:915-20.
    • (2000) Circulation , vol.102 , pp. 915-920
    • Jeremias, I.1    Kupatt, C.2    Martin-Villalba, A.3
  • 28
    • 0032489353 scopus 로고    scopus 로고
    • TRUNDD, a new member of thr TRAIL receptor family that antagonizes TRAIL signalling
    • DOI 10.1016/S0014-5793(98)00135-5, PII S0014579398001355
    • Pan G, Ni J, Yu G, et al. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett. 1998;424:41-5. (Pubitemid 28130348)
    • (1998) FEBS Letters , vol.424 , Issue.1-2 , pp. 41-45
    • Pan, G.1    Ni, J.2    Yu, G.-L.3    Wei, Y.-F.4    Dixit, V.M.5
  • 29
    • 0030762815 scopus 로고    scopus 로고
    • An antagonist decoy receptor and a death domain-containing receptor for TRAIL
    • DOI 10.1126/science.277.5327.815
    • Pan G, Ni J, Wei YF, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 1997;277:815-8. (Pubitemid 27366732)
    • (1997) Science , vol.277 , Issue.5327 , pp. 815-818
    • Pan, G.1    Ni, J.2    Wei, Y.-F.3    Yu, G.-I.4    Gentz, R.5    Dixit, V.M.6
  • 30
    • 4544265332 scopus 로고    scopus 로고
    • Duality of innate stress responses in cardiac injury, repair, and remodeling
    • DOI 10.1016/j.yjmcc.2004.05.028, PII S0022282804001701
    • Wilson EM, Diwan A, Spinale FG, Mann DL. Duality of innate stress responses in cardiac injury, repair, and remodeling. J Mol Cell Cardiol. 2004;37:801-11. (Pubitemid 39222072)
    • (2004) Journal of Molecular and Cellular Cardiology , vol.37 , Issue.4 , pp. 801-811
    • Wilson, E.M.1    Diwan, A.2    Spinale, F.G.3    Mann, D.L.4
  • 31
    • 0035957036 scopus 로고    scopus 로고
    • Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
    • Bozkurt B, Torre-Amione G, Warren MS, et al. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001;103:1044-7. (Pubitemid 32200174)
    • (2001) Circulation , vol.103 , Issue.8 , pp. 1044-1047
    • Bozkurt, B.1    Torre-Amione, G.2    Warren, M.S.3    Whitmore, J.4    Soran, O.Z.5    Feldman, A.M.6    Mann, D.L.7
  • 32
    • 0038755661 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial
    • DOI 10.1161/01.CIR.0000077913.60364.D2
    • Chung ES, Packer M, Lo KH, et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003;107:3133-40. (Pubitemid 36793081)
    • (2003) Circulation , vol.107 , Issue.25 , pp. 3133-3140
    • Chung, E.S.1    Packer, M.2    Lo, K.H.3    Fasanmade, A.A.4    Willerson, J.T.5
  • 34
    • 64549091508 scopus 로고    scopus 로고
    • Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
    • Heymans S, Hirsch E, Anker SD, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11:119-29.
    • (2009) Eur J Heart Fail , vol.11 , pp. 119-129
    • Heymans, S.1    Hirsch, E.2    Anker, S.D.3
  • 35
    • 0032746314 scopus 로고    scopus 로고
    • Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors
    • Darnay BG, Aggarwal BB. Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors. Ann Rheum Dis. 1999;58 Suppl 1:I2-I13.
    • (1999) Ann Rheum Dis. , vol.58 , Issue.SUPPL. 1
    • Darnay, B.G.1    Aggarwal, B.B.2
  • 36
    • 0038813632 scopus 로고    scopus 로고
    • Apoptosis in heart: Basic mechanisms and implications in cardiovascular diseases
    • DOI 10.1016/S1471-4914(03)00025-X
    • Kang PM, Izumo S. Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med. 2003;9:177-82. (Pubitemid 36626707)
    • (2003) Trends in Molecular Medicine , vol.9 , Issue.4 , pp. 177-182
    • Kang, P.M.1    Izumo, S.2
  • 37
    • 11144307292 scopus 로고    scopus 로고
    • STRESS signaling pathways that modulate cardiac myocyte apoptosis
    • DOI 10.1016/j.yjmcc.2004.11.004, PII S0022282804003256
    • Baines CP, Molkentin JD. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol. 2005;38:47-62. (Pubitemid 40038651)
    • (2005) Journal of Molecular and Cellular Cardiology , vol.38 , Issue.1 , pp. 47-62
    • Baines, C.P.1    Molkentin, J.D.2
  • 38
    • 0037230940 scopus 로고    scopus 로고
    • Acute and chronic endothelial dysfunction: Implications for the development of heart failure
    • DOI 10.1023/A:1022151106019
    • Linke A, Recchia F, Zhang X, Hintze TH. Acute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev. 2003;8:87-97. (Pubitemid 36342292)
    • (2003) Heart Failure Reviews , vol.8 , Issue.1 , pp. 87-97
    • Linke, A.1    Recchia, F.2    Zhang, X.3    Hintze, T.H.4
  • 39
    • 0642342931 scopus 로고    scopus 로고
    • Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
    • DOI 10.1016/S0008-6363(03)00362-6, PII S0008636303003626
    • Yndestad A, Holm AM, Muller F, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res. 2003;60:141-6. (Pubitemid 38373485)
    • (2003) Cardiovascular Research , vol.60 , Issue.1 , pp. 141-146
    • Yndestad, A.1    Holm, A.M.2    Muller, F.3    Simonsen, S.4    Froland, S.S.5    Gullestad, L.6    Aukrust, P.7
  • 42
    • 0036273957 scopus 로고    scopus 로고
    • Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes
    • DOI 10.1016/S0008-6363(02)00264-X, PII S000863630200264X
    • Yaniv G, Shilkrut M, Lotan R, et al. Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes. Cardiovasc Res. 2002;54:611-23. (Pubitemid 34595420)
    • (2002) Cardiovascular Research , vol.54 , Issue.3 , pp. 611-623
    • Yaniv, G.1    Shilkrut, M.2    Lotan, R.3    Berke, G.4    Larisch, S.5    Binah, O.6
  • 43
    • 0038320035 scopus 로고    scopus 로고
    • Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy
    • DOI 10.1016/S1359-6101(03)00029-7
    • Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev. 2003;14:337-48. (Pubitemid 36693152)
    • (2003) Cytokine and Growth Factor Reviews , vol.14 , Issue.3-4 , pp. 337-348
    • Almasan, A.1    Ashkenazi, A.2
  • 44
    • 0035992505 scopus 로고    scopus 로고
    • On the TRAIL to apoptosis
    • DOI 10.1016/S1359-6101(02)00006-0, PII S1359610102000060
    • Baetu TM, Hiscott J. On the TRAIL to apoptosis. Cytokine Growth Factor Rev. 2002;13:199-207. (Pubitemid 34693174)
    • (2002) Cytokine and Growth Factor Reviews , vol.13 , Issue.3 , pp. 199-207
    • Baetu, T.M.1    Hiscott, J.2
  • 45
    • 64549087652 scopus 로고    scopus 로고
    • Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: Role of nuclear factor-kappaB and inflammatory activation
    • This experimental study illustrates the complexity of the interplay between TNF-related molecules in HF by showing disparate and opposing effects by TNFR1 and TNFR2 on myocardial remodeling, hypertrophy, NF-κB activation, inflammation, and apoptosis
    • Hamid T, Gu Y, Ortines RV, et al. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation. 2009;119:1386-97. This experimental study illustrates the complexity of the interplay between TNF-related molecules in HF by showing disparate and opposing effects by TNFR1 and TNFR2 on myocardial remodeling, hypertrophy, NF-κB activation, inflammation, and apoptosis.
    • (2009) Circulation , vol.119 , pp. 1386-1397
    • Hamid, T.1    Gu, Y.2    Ortines, R.V.3
  • 51
    • 0037311527 scopus 로고    scopus 로고
    • Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts
    • DOI 10.1165/rcmb.2002-0140OC
    • Yurovsky VV. Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts. Am J Respir Cell Mol Biol. 2003;28:225-31. (Pubitemid 36169652)
    • (2003) American Journal of Respiratory Cell and Molecular Biology , vol.28 , Issue.2 , pp. 225-231
    • Yurovsky, V.V.1
  • 52
    • 80053124249 scopus 로고    scopus 로고
    • TNFalpha increases cardiac fibroblast lysyl oxidase expression through TGF-beta and PI3Kinase signaling pathways
    • This study illustrates the complex role of TNF-related molecules in ECM remodeling, promoting both matrix degradation and enhanced collagen synthesis partly depending on co-stimuli and concentration of TNF-related molecule
    • Voloshenyuk TG, Hart AD, Khoutorova E, Gardner JD. TNFalpha increases cardiac fibroblast lysyl oxidase expression through TGF-beta and PI3Kinase signaling pathways. Biochem Biophys Res Commun. 2011;413:370-5. This study illustrates the complex role of TNF-related molecules in ECM remodeling, promoting both matrix degradation and enhanced collagen synthesis partly depending on co-stimuli and concentration of TNF-related molecule.
    • (2011) Biochem Biophys Res Commun. , vol.413 , pp. 370-375
    • Voloshenyuk, T.G.1    Hart, A.D.2    Khoutorova, E.3    Gardner, J.D.4
  • 54
    • 45849111384 scopus 로고    scopus 로고
    • Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease
    • Liu W, Feng W, Wang F, et al. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease. Exp Mol Pathol. 2008;84:213-7.
    • (2008) Exp Mol Pathol , vol.84 , pp. 213-217
    • Liu, W.1    Feng, W.2    Wang, F.3
  • 55
    • 80054034731 scopus 로고    scopus 로고
    • Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
    • Ueland T, Aukrust P, Dahl CP, et al. Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis. J Intern Med. 2011;270:452-60.
    • (2011) J Intern Med , vol.270 , pp. 452-460
    • Ueland, T.1    Aukrust, P.2    Dahl, C.P.3
  • 56
    • 0037644721 scopus 로고    scopus 로고
    • Biology of the TRANCE axis
    • DOI 10.1016/S1359-6101(03)00027-3
    • Walsh MC, Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 2003;14:251-63. (Pubitemid 36693145)
    • (2003) Cytokine and Growth Factor Reviews , vol.14 , Issue.3-4 , pp. 251-263
    • Walsh, M.C.1    Choi, Y.2
  • 57
    • 70350575289 scopus 로고    scopus 로고
    • IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenolinduced heart failure
    • Feng W, Li W, Liu W, et al. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenolinduced heart failure. Exp Mol Pathol. 2009;87:212-8.
    • (2009) Exp Mol Pathol , vol.87 , pp. 212-218
    • Feng, W.1    Li, W.2    Liu, W.3
  • 60
    • 64849108593 scopus 로고    scopus 로고
    • Prognostic value of apoptosis markers in advanced heart failure patients
    • This study describes discrepant effects of soluble TNF-related markers of apoptosis on the prognosis of advanced HF and indicates that sTRAIL could be of interest as a therapeutic agent. It also illustrates the importance of fully understanding pathophysiological processes before selecting specific pathways as therapeutic target
    • Niessner A, Hohensinner PJ, Rychli K, et al. Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J. 2009;30:789-96. This study describes discrepant effects of soluble TNF-related markers of apoptosis on the prognosis of advanced HF and indicates that sTRAIL could be of interest as a therapeutic agent. It also illustrates the importance of fully understanding pathophysiological processes before selecting specific pathways as therapeutic target.
    • (2009) Eur Heart J. , vol.30 , pp. 789-796
    • Niessner, A.1    Hohensinner, P.J.2    Rychli, K.3
  • 61
    • 77952427166 scopus 로고    scopus 로고
    • An imbalanced OPG/ TRAIL ratio is associated to severe acute myocardial infarction
    • Secchiero P, Corallini F, Beltrami AP, et al. An imbalanced OPG/ TRAIL ratio is associated to severe acute myocardial infarction. Atherosclerosis. 2010;210:274-7.
    • (2010) Atherosclerosis , vol.210 , pp. 274-277
    • Secchiero, P.1    Corallini, F.2    Beltrami, A.P.3
  • 62
    • 77950605368 scopus 로고    scopus 로고
    • TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL
    • Corallini F, Secchiero P, Beltrami AP, et al. TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. Cell Mol Life Sci. 2010;67:1307-14.
    • (2010) Cell Mol Life Sci , vol.67 , pp. 1307-1314
    • Corallini, F.1    Secchiero, P.2    Beltrami, A.P.3
  • 63
    • 77955456565 scopus 로고    scopus 로고
    • Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial
    • Roysland R, Masson S, Omland T, et al. Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. Am Heart J. 2010;160:286-93.
    • (2010) Am Heart J , vol.160 , pp. 286-293
    • Roysland, R.1    Masson, S.2    Omland, T.3
  • 64
    • 79955929820 scopus 로고    scopus 로고
    • Osteoprotegerin predicts progression of chronic heart failure: Results from CORONA
    • Ueland T, Dahl CP, Kjekshus J, et al. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. Circ Heart Fail. 2011;4:145-52.
    • (2011) Circ Heart Fail , vol.4 , pp. 145-152
    • Ueland, T.1    Dahl, C.P.2    Kjekshus, J.3
  • 66
    • 79953751008 scopus 로고    scopus 로고
    • Osteoporosis: Now and the future
    • Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377:1276-87.
    • (2011) Lancet , vol.377 , pp. 1276-1287
    • Rachner, T.D.1    Khosla, S.2    Hofbauer, L.C.3
  • 67
    • 43549099569 scopus 로고    scopus 로고
    • Biomarkers in heart failure
    • Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358:2148-59.
    • (2008) N Engl J Med , vol.358 , pp. 2148-2159
    • Braunwald, E.1
  • 68
    • 33847327365 scopus 로고    scopus 로고
    • Benchmarks for the assessment of novel cardiovascular biomarkers
    • DOI 10.1161/CIRCULATIONAHA.106.683110, PII 0000301720070227000004
    • Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation. 2007;115:949-52. (Pubitemid 46328287)
    • (2007) Circulation , vol.115 , Issue.8 , pp. 949-952
    • Morrow, D.A.1    De Lemos, J.A.2
  • 69
    • 0034687595 scopus 로고    scopus 로고
    • Plasma cytokine parameters and mortality in patients with chronic heart failure
    • Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102:3060-7.
    • (2000) Circulation , vol.102 , pp. 3060-3067
    • Rauchhaus, M.1    Doehner, W.2    Francis, D.P.3
  • 71
    • 0035942264 scopus 로고    scopus 로고
    • Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone Trial (VEST)
    • Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001;103:2055-9. (Pubitemid 32373007)
    • (2001) Circulation , vol.103 , Issue.16 , pp. 2055-2059
    • Deswal, A.1    Petersen, N.J.2    Feldman, A.M.3    Young, J.B.4    White, B.G.5    Mann, D.L.6
  • 72
    • 41449114378 scopus 로고    scopus 로고
    • Prognostic role of proand anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure
    • Miettinen KH, Lassus J, Harjola VP, et al. Prognostic role of proand anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail. 2008;10:396-403.
    • (2008) Eur J Heart Fail , vol.10 , pp. 396-403
    • Miettinen, K.H.1    Lassus, J.2    Harjola, V.P.3
  • 77
    • 70350673929 scopus 로고    scopus 로고
    • Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure
    • Chorianopoulos E, Rosenberg M, Zugck C, et al. Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure. Eur J Heart Fail. 2009;11:1050-6.
    • (2009) Eur J Heart Fail , vol.11 , pp. 1050-1056
    • Chorianopoulos, E.1    Rosenberg, M.2    Zugck, C.3
  • 78
    • 78649736865 scopus 로고    scopus 로고
    • Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure
    • Richter B, Rychli K, Hohensinner PJ, et al. Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure. Atherosclerosis. 2010;213:545-8.
    • (2010) Atherosclerosis , vol.213 , pp. 545-548
    • Richter, B.1    Rychli, K.2    Hohensinner, P.J.3
  • 79
    • 0029117828 scopus 로고
    • Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
    • Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92:1479-86.
    • (1995) Circulation , vol.92 , pp. 1479-1486
    • Ferrari, R.1    Bachetti, T.2    Confortini, R.3
  • 80
    • 28244446690 scopus 로고    scopus 로고
    • Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients
    • DOI 10.1016/j.jacc.2005.08.039, PII S0735109705021935
    • Ueland T, Kjekshus J, Froland SS, et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol. 2005;46:2018-21. (Pubitemid 41713585)
    • (2005) Journal of the American College of Cardiology , vol.46 , Issue.11 , pp. 2018-2021
    • Ueland, T.1    Kjekshus, J.2    Froland, S.S.3    Omland, T.4    Squire, I.B.5    Gullestad, L.6    Dickstein, K.7    Aukrust, P.8
  • 81
    • 56749173769 scopus 로고    scopus 로고
    • The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: A systematic literature review
    • Nybo M, Rasmussen LM. The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review. Eur J Endocrinol. 2008;159:603-8.
    • (2008) Eur J Endocrinol , vol.159 , pp. 603-608
    • Nybo, M.1    Rasmussen, L.M.2
  • 82
    • 34249325167 scopus 로고    scopus 로고
    • Plasma osteoprotegerin levels in the general population: Relation to indices of left ventricular structure and function
    • DOI 10.1161/HYPERTENSIONAHA.107.087742, PII 0000426820070600000036
    • Omland T, Drazner MH, Ueland T, et al. Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function. Hypertension. 2007;49:1392-8. (Pubitemid 46809385)
    • (2007) Hypertension , vol.49 , Issue.6 , pp. 1392-1398
    • Omland, T.1    Drazner, M.H.2    Ueland, T.3    Abedin, M.4    Murphy, S.A.5    Aukrust, P.6    De Lemos, J.A.7
  • 84
    • 8744309820 scopus 로고    scopus 로고
    • Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state
    • DOI 10.1111/j.1365-2362.2004.01414.x
    • Jellema A, Plat J, Mensink RP. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest. 2004;34:766-73. (Pubitemid 39524302)
    • (2004) European Journal of Clinical Investigation , vol.34 , Issue.11 , pp. 766-773
    • Jellema, A.1    Plat, J.2    Mensink, R.P.3
  • 85
    • 2442457425 scopus 로고    scopus 로고
    • Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers
    • DOI 10.1016/j.bbi.2003.12.009, PII S0889159104000194
    • Haack M, Pollmacher T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain Behav Immun. 2004;18:361-7. (Pubitemid 38648833)
    • (2004) Brain, Behavior, and Immunity , vol.18 , Issue.4 , pp. 361-367
    • Haack, M.1    Pollmacher, T.2    Mullington, J.M.3
  • 86
    • 33646539111 scopus 로고    scopus 로고
    • The tumor necrosis factor superfamily in heart failure
    • Ueland T, Aukrust P, Damas JK, et al. The tumor necrosis factor superfamily in heart failure. Future Cardiol. 2006;2:101-11.
    • (2006) Future Cardiol , vol.2 , pp. 101-111
    • Ueland, T.1    Aukrust, P.2    Damas, J.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.